Winship Cancer Institute of Emory University
LightNews LightNews
banner
winshipcancer.emory.edu
Winship Cancer Institute of Emory University
@winshipcancer.emory.edu
460 followers 130 following 91 posts
As Georgia’s only NCI-Designated Comprehensive Cancer Center, we are dedicated to the prevention, treatment and control of cancer. #WhereScienceBecomesHope

https://winshipcancer.emory.edu
Posts Replies Media Videos
Reposted by Winship Cancer Institute of Emory University
acadrad.bsky.social
Announcing the Academy’s 2025 Gold Medal recipient, Dr. Lewin, MD, FACR! 🏅

This prestigious award recognizes extraordinary contributions to advancing imaging and radiology research. Click the link to learn more www.acadrad.org/wp-content/u.... @emoryradiology.bsky.social @winshipcancer.emory.edu
September 24, 2025 at 6:12 PM
winshipcancer.emory.edu
We’re celebrating one year of Winship’s HDR brachytherapy program at Emory Midtown! 🎉 Since its launch, the program has expanded access to advanced, image-guided cancer care in a state-of-the-art operative suite.

Read more ➡️ brnw.ch/21wW3Jm
September 25, 2025 at 2:52 PM
winshipcancer.emory.edu
🎉 Winship, through generous support from the Arthur M. Blank Family Foundation and in collaboration with Mount Sinai Health System, celebrated the launch of the new Winship Mobile Prostate Cancer Screening Program today at a community event inside Mercedes-Benz Stadium. ➡️ brnw.ch/21wVpyk
September 2, 2025 at 9:48 PM
winshipcancer.emory.edu
Winship epidemiologist Michael Goodman, MD, MPH, collaborates with India’s Center for Chronic Disease Control to strengthen cancer surveillance systems and improve how cases are tracked.

Read more ➡️ brnw.ch/21wV7KI
August 22, 2025 at 3:29 PM
winshipcancer.emory.edu
Winship investigators have been awarded a total of $400,000 to support eight new projects through Winship Invest$, a peer-reviewed program designed to accelerate innovative cancer research. Learn more ➡️ brnw.ch/21wUWPO
August 18, 2025 at 3:10 PM
Reposted by Winship Cancer Institute of Emory University
onclive.bsky.social
FDA Approval of Mirdametinib Reduces Treatment Barriers for Adult Patients With NF1-Associated PNs @winshipcancer.emory.edu #oncology
www.onclive.com/view/fda-app...
FDA Approval of Mirdametinib Reduces Treatment Barriers for Adult Patients With NF1-Associated PNs
Timothy Gershon, MD, PhD, discusses how the FDA approval of mirdametinib will affect the treatment paradigm for adult patients with NF1-associated PNs.
www.onclive.com
August 7, 2025 at 7:06 PM
winshipcancer.emory.edu
One of the biggest challenges in cancer care is when patients stop responding to treatment. A new study led by Mourad Zerfaoui, PhD, reveals how loss of a molecule called AHR fuels drug resistance in BRAF-mutant melanoma and thyroid cancer. 🔗 brnw.ch/21wUGp7
August 6, 2025 at 2:29 PM
Reposted by Winship Cancer Institute of Emory University
chrystalpaulos.bsky.social
www.v.org/grants/chrys...
Honored to be awarded the All-Star V Foundation grant! Inspired by great team efforts between #Paulos and #Lesinski labs! Props to cell therapy gurus @megen-w.bsky.social #AnnaCole @meganmw.bsky.social and crew @winshipcancer.emory.edu
Chrystal Paulos, PhD - V Foundation
Melanoma is a serious and often deadly type of skin cancer. Although immunotherapy has saved many lives, it still doesn’t work for every patient. Our lab is developing ways to give the immune system a...
www.v.org
August 1, 2025 at 11:24 AM
winshipcancer.emory.edu
That wraps up the first segment of the lymphoma session at #DDHO2025, closing with a patient-centered panel discussion featuring EHA highlights and a dynamic Q&A.
July 25, 2025 at 1:42 PM
winshipcancer.emory.edu
Day 2 of #DDHO2025 is underway, kicking off with the first lymphoma session.
July 25, 2025 at 12:09 PM
winshipcancer.emory.edu
Debate: early vs delayed transplantation in myelofibrosis

Amelia Langston, MD argues for early ☀️

Michael Hochman, MD argues for delayed ⏰

#DDHO2025
July 24, 2025 at 4:25 PM
winshipcancer.emory.edu
Are ADCs Highly Promising for the Treatment of NSCLC...or... ADCs are the Futures of NSCLC?

Winship’s Conor E. Steuer, MD argues yes! #DDHO2025
July 24, 2025 at 12:12 PM
winshipcancer.emory.edu
Winship executive director Suresh Ramalingam, MD, and Winship chief medical officer Sagar Lonial, MD, kick off this year’s #DDHO2025 🎉
July 24, 2025 at 12:09 PM
winshipcancer.emory.edu
Kicking off #DDHO25 👏
July 24, 2025 at 11:57 AM
Reposted by Winship Cancer Institute of Emory University
oncodaily.bsky.social
Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute
@winshipcancer.emory.edu

oncodaily.com/career/jill-...

#OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews
Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute - OncoDaily
Jill Barnholtz-Sloan Has Been Appointed Chief Administrative Officer and Associate Director at Winship Cancer Institute / cancer, Emory University, Jill
oncodaily.com
July 20, 2025 at 1:52 PM
winshipcancer.emory.edu
Winship urologist Vikram Narayan, MD, FACS, was profiled by Apple for Emory Healthcare's use of Apple technology to streamline workflows and enhance patient care. 🎥 Read more and Watch the video ➡️ brnw.ch/21wUcrF
July 17, 2025 at 2:05 PM
winshipcancer.emory.edu
Winship thoracic oncologist Fatemeh Ardeshir, MD, MSc. commented on the new FDA-approved treatment option, Datroway (datopotamab deruxtecan or Dato-DXd).

The treatment is now available for people with non-small cell lung cancer (NSCLC) who harbor a common EGFR mutation. Learn more: brnw.ch/21wUbRP
July 16, 2025 at 3:25 PM
winshipcancer.emory.edu
🎗️ July is Sarcoma Awareness Month. Sarcomas are rare cancers—making up less than 1% of adult cases—with 150+ types that require expert care.

Sarcoma expert Kenneth Cardona, MD, FACS, says their rarity makes diagnosis and treatment especially challenging. Learn more ➡️ brnw.ch/21wU8tY
July 14, 2025 at 5:46 PM
winshipcancer.emory.edu
🎉Seventy-three Winship physicians were selected by their peers as "Top Doctors" for Atlanta magazine's 2025 list of the city's best doctors.
July 9, 2025 at 1:35 PM
Reposted by Winship Cancer Institute of Emory University
lesinskilab.bsky.social
Check out our new paper in Hepatology on how myeloid cells limit immunotherapy in preclinical cholangiocarcinoma models!
Disease site matters! @chrystalpaulos.bsky.social @megen-w.bsky.social @winshipcancer.emory.edu many others!

pubmed.ncbi.nlm.nih.gov/40590857/
Tumor site influences efficacy of MEKi and immunotherapy combinations in pre-clinical model of cholangiocarcinoma - PubMed
These findings identify myeloid cells as key mediators of both immunotherapy resistance and toxicity in CCA, highlighting the critical importance of tumor site and use of physiologically relevant pre-...
pubmed.ncbi.nlm.nih.gov
July 3, 2025 at 1:06 PM
Reposted by Winship Cancer Institute of Emory University
cancerletter.com
Neil Iyengar joins @winshipcancer.emory.edu‬ as survivorship director, co-director of Breast Oncology Program
https://cancerletter.com/in-brief/20250703_7a/
Neil Iyengar joins Winship as survivorship director, co-director of Breast Oncology Program - The Cancer Letter
Breast medical oncologist and cancer survivorship expert Neil M. Iyengar was appointed director of survivorship services at Winship Cancer Institute of Emory University. To access this subscriber-only content please log in or subscribe.If your institution has a site license, log in with IP-login or register for a sponsored account.**Not all site licenses are enrolled in […]
cancerletter.com
July 5, 2025 at 12:00 PM
winshipcancer.emory.edu
🎊Joining Winship on July 1, breast medical oncologist and cancer survivorship expert Neil M. Iyengar, MD, has been appointed director of survivorship services at Winship Cancer Institute of Emory University.

Read more ➡️ brnw.ch/21wTPea
July 2, 2025 at 3:53 PM
winshipcancer.emory.edu
Winship medical oncologist Kevin Kalinsky, MD, MS, FASCO, discusses how findings from the phase 3 SERENA-6 trial reinforce the importance of timely ESR1 testing in HR-positive breast cancer.

Read more ➡️ brnw.ch/21wTOyy
July 1, 2025 at 3:51 PM
winshipcancer.emory.edu
“Can I take this supplement?” It’s a common question after a cancer diagnosis—but it’s just one part of a bigger picture. At Winship, Naturopathic Doctor serving as an Integrative Oncology Specialist Anna Bausum, ND, FABNO, helps patients build a strong foundation to support healing. brnw.ch/21wTN9a
June 30, 2025 at 8:37 PM
winshipcancer.emory.edu
🔬 Can AI paint a fuller picture of cancer?

Winship researchers, including Anant Madabhushi, PhD, and Nabil F. Saba, MD, FACP, are using AI to combine CT scans, tissue slides and epigenetic data to better predict cancer outcomes—especially for head and neck cancers. ➡️ brnw.ch/21wTHzS
Emory experts discover new insights into head and neck cancers | Emory University | Atlanta GA
Experts at Emory are utilizing artificial intelligence to break down the boundaries between different types of imaging, combining them to yield deeper insights into cancer risk and prognosis, showing ...
brnw.ch
June 26, 2025 at 1:15 PM